Back
Blueprint for Far-UVC
webCredibility Rating
4/5
High(4)High quality. Established institution or organization with editorial oversight and accountability.
Rating inherited from publication venue: Blueprint Biosecurity
Relevant to AI safety audiences insofar as biosecurity and pandemic prevention overlap with catastrophic risk reduction; far-UVC represents a technical intervention for reducing biological existential and global catastrophic risks independent of AI.
Metadata
Importance: 52/100organizational reportanalysis
Summary
This resource outlines a strategic blueprint for accelerating the development and deployment of far-UVC light technology as a biosecurity intervention to reduce airborne pathogen transmission. It addresses technical, regulatory, and policy barriers to widespread adoption of far-UVC as a passive, scalable tool for pandemic prevention. The blueprint positions far-UVC as a key component of a broader biosecurity infrastructure.
Key Points
- •Far-UVC light (around 222nm wavelength) can inactivate airborne pathogens including viruses and bacteria without harming human tissue, making it safe for occupied spaces.
- •The blueprint identifies key obstacles to deployment including regulatory approval gaps, manufacturing scale limitations, and lack of standardized safety and efficacy guidelines.
- •Accelerating far-UVC adoption could serve as a generalized defense against both natural pandemics and potential bioterrorism or engineered pathogen threats.
- •Policy recommendations include government procurement commitments, updated safety standards, and funding for further efficacy research in real-world settings.
- •Far-UVC is presented as a cost-effective, passive intervention requiring minimal behavior change, making it viable at population scale.
Cited by 1 page
| Page | Type | Quality |
|---|---|---|
| Blueprint Biosecurity | Organization | 60.0 |
Cached Content Preview
HTTP 200Fetched Apr 9, 20263 KB
Blueprint for Far-UVC – Blueprint Biosecurity
Programs
Far-UVC
PPE
Glycol vapors
Funded Projects
Calls for Proposals
Publications
News
Team
Careers
Contact
Copyright © 2026 Blueprint Biosecurity - All Rights Reserved.
Privacy Policy & Cookies
Publication: Blueprint for Far-UVC
Our Blueprint for Far-UVC report contains a comprehensive overview of the current state of knowledge for far-UVC, as well as a series of recommendations for advancing the technology’s development. The Far-UVC Blueprint is a culmination of nearly two years of work, consisting of an extensive review of published literature and hundreds of interviews with experts across multiple disciplines.
It examines far-UVC’s efficacy at inactivating pathogens within safe human exposure limits, its photobiological safety for skin and eyes, and potential concerns like ozone generation. It outlines key recommendations for accelerating development, including research priorities to establish effective installation designs, identify biological effects, understand indoor air quality impacts, and obtain real-world effectiveness evidence. The report also details current emitter technologies, regulatory frameworks, UVC’s effects on materials, and considers ozone mitigation strategies. Overall, the report suggests that far-UVC technology could be a significant advancement in airborne infection control if certain research priorities and implementation guidelines are addressed.
Suggested citation: Blueprint for Far-UVC. (2025). Blueprint Biosecurity. https://doi.org/10.64046/5j7b3nac
Blueprint for Far-UVC Executive Summary
Blueprint for Far-UVC
Related Links
Launching the far-UVC Blueprint
06/05/25
Releasing the final version of our far-UVC Blueprint
Read story +
Introducing the AIR Program
03/31/25
Our research program for speeding up far-UVC's widespread adoption
Read story +
Far-UVC is a new form of germicidal UV light (GUV). Because it is strongly absorbed by proteins in the outer layer of human skin and eyes, it can inactivate a wide range of pathogens with minimal penetration into and effects on human tissues. This enables higher human exposure limits, unlocking the potential for disinfecting occupied spaces continuously while achieving significantly improved air cleaning over current alternatives. Far-UVC is also silent, energy efficient, commercially viable at scale, less vulnerable to engendering resistance than pharmaceuticals, and can be deployed in advance of an outbreak to help prevent a pandemic from occurring in the first place.
view program
... (truncated, 3 KB total)Resource ID:
df03adbf659af89e | Stable ID: sid_YCkzBRgMLK